Feldan Bio inc.: federal grants and contributions: 17 agreements; $3.0M value; 3 departments; 8 programs.
Assay record ASY-CA-1KH29950AF · Cite as: Assay Systems, “Feldan Bio inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/feldan-bio-inc/
Natural killer (NK) cells play a crucial role in the control of tumors, making them appealing for immunotherapy. Alongside Green Cross LabCell, Feldan aims to genetically modify NK cells to improve their potential for allogeneic engraftment and their cytotoxicity against tumors. This project will lead to the development of universal, off-the-shelf and hyperactive NK cells for immuno-oncology therapies.
Development of a treatment for mucus hypersecretion associated with pulmonary diseases by delivery of antisense oligonucleotides using Feldan Shuttle technology
Development of an intracellular RNA delivery tool using the Feldan Shuttle, a novel peptide-based delivery platform.
Monies allocated over more than one fiscal year;Repayable Contribution
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
;Repayable Contribution
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
Development of a peptide-based technology that allows the delivery of various therapeutic compounds inside cells.
Development of a peptide-based technology that allows the delivery of various therapeutic compounds inside cells.
The project will support development of intellectual property capacity within the firm.
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
All grants from Canada Economic Development for Quebec Regions
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.